TY  - JOUR
A1  - Kretzschmar, Kai
T1  - Cancer research using organoid technology
JF  - Journal of Molecular Medicine
N2  - Organoid technology has rapidly transformed basic biomedical research and contributed to significant discoveries in the last decade. With the application of protocols to generate organoids from cancer tissue, organoid technology has opened up new opportunities for cancer research and therapy. Using organoid cultures derived from healthy tissues, different aspects of tumour initiation and progression are widely studied including the role of pathogens or specific cancer genes. Cancer organoid cultures, on the other hand, are applied to generate biobanks, perform drug screens, and study mutational signatures. With the incorporation of cellular components of the tumour microenvironment such as immune cells into the organoid cultures, the technology is now also exploited in the rapidly advancing field of immuno-oncology. In this review, I discuss how organoid technology is currently being utilised in cancer research and what obstacles are still to be overcome for its broader use in anti-cancer therapy.
KW  - cancer
KW  - organoids
KW  - 3D culture
KW  - pre-clinical models
KW  - personalised medicine
KW  - drug screening
KW  - immuno-oncology
Y1  - 2020
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-235377
SN  - 0946-2716
VL  - 99
ER  -